Kaempferol

Category
flavonoid
Routes
Oral (PO)
Half-Life (t½)
PO: 4h
Formula
C15H10O6
Molecular Weight
286.24 g/mol
PubChem CID
5280863
Aliases
3,4′,5,7-tetrahydroxyflavone

Pharmacological Mechanism

Flavonol with ER-α binding (weak phytoestrogen activity), Nrf2 activation, and mTOR inhibition. Gut-microbial conversion yields phloroglucinol-type metabolites. Anti-angiogenic effects reported in tumour models (VEGF pathway modulation).

Half-Life & Elimination Curve (PO: 4h)

100%50%25%12.5%0%0h0×t½4h1×t½8h2×t½12h3×t½16h4×t½20h5×t½0×t½ (0h): 100% remaining (~0.959 µg/L)1×t½ (4h): 50% remaining (~0.48 µg/L)2×t½ (8h): 25% remaining (~0.24 µg/L)3×t½ (12h): 12.5% remaining (~0.12 µg/L)4×t½ (16h): 6.3% remaining (~0.0599 µg/L)5×t½ (20h): 3.1% remaining (~0.03 µg/L)
Plasma (PO)t½ Decay (4h)
  • 0×t½0h100% (0.959 µg/L)
  • 1×t½4h50% (0.48 µg/L)
  • 2×t½8h25% (0.24 µg/L)
  • 3×t½12h12.5% (0.12 µg/L)
  • 4×t½16h6.3% (0.0599 µg/L)
  • 5×t½20h3.1% (0.03 µg/L)
Elimination t½4h (PO)
Rate Constant (ke)0.173 h⁻¹
Time to Peak (Tmax)2.91h
Est. Peak (Cmax)0.959 µg/L
Clearance (CL)14.6 L/h
97% Washout (5×t½)20h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References